Skip to content

Immunovant, Inc. IMVT Balance Sheet Statement

TTM Q4 '26TTM Q3 '26TTM Q2 '26TTM Q1 '26TTM Q4 '25
$902.11M-9.3%$994.53M+90.6%$521.87M-12.9%$598.91M-16.1%$713.97M+90.6%
$6.68M-12.5%$7.63M-7.1%$8.21M+1.2%$8.12M-5.6%$8.6M-27.4%
$948.82M-9.0%$1.04B+81.8%$573.55M-12.0%$651.76M-15.1%$767.66M+86.1%
$443K-16.6%$531K-16.0%$632K-14.2%$737K-12.7%$844K+12.2%
$957.01M-9.1%$1.05B+80.5%$582.96M-11.9%$661.44M-14.8%$776.22M+84.4%
$7.54M-12.5%$8.62M+24.6%$6.92M-11.8%$7.84M-55.6%$17.66M-10.9%
$104.42M+57.6%$66.26M+4.7%$63.25M+19.6%$52.9M-23.1%$68.78M+0.7%
$104.42M+57.6%$66.26M+4.7%$63.25M+19.6%$52.9M-23.1%$68.78M+0.7%
$20K-100.0%$500M0.0%$500M0.0%$500M+3,124,900%$16K-100.0%
-$1.75B-9.3%-$1.6B-7.4%-$1.49B-9.3%-$1.36B-9.7%-$1.24B-9.4%
$852.59M-13.5%$986.14M+89.7%$519.71M-14.6%$608.54M-14.0%$707.45M+101%
$957.01M-9.1%$1.05B+80.5%$582.96M-11.9%$661.44M-14.8%$776.22M+84.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Immunovant, Inc.'s total assets?
Immunovant, Inc. (IMVT) holds $957.0M in total assets, up 23.3% year over year.
How much debt does Immunovant, Inc. have?
Immunovant, Inc. carries $72.0K in total debt against $852.6M of shareholders' equity, a debt-to-equity ratio of 0.00.
How much cash does Immunovant, Inc. have?
Immunovant, Inc. holds $902.1M in cash and equivalents.
Can Immunovant, Inc. cover its short-term obligations?
Its current ratio is 9.09 — current assets exceed current liabilities.
Where does Immunovant, Inc.'s balance sheet data come from?
Every line is extracted from Immunovant, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.